Recap: Supernus Pharmaceuticals Q4 Earnings

Supernus Pharmaceuticals SUPN reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Supernus Pharmaceuticals missed estimated earnings by -28.999999999999996%, reporting an EPS of $0.39 versus an estimate of $0.55.

Revenue was down $3.01 million from the same period last year.

Last quarter the company missed on EPS by $0.42 which was followed by a 11.0% increase in the share price the next day.

Here's a look at Supernus Pharmaceuticals's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.13	-0.23	0.17	0.68
EPS Actual	-0.29	-0.02	0.29	0.43
Revenue Estimate	146.14M	144.38M	139.02M	180.37M
Revenue Actual	153.88M	135.56M	153.76M	167.33M

To track all earnings releases for Supernus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar